The Profound Impacts of Precision Medicine, Genomic Sequencing on Cancer Care
Precision Oncology is helping NCI treat cancer based on specific genetic changes in a patient’s tumor by allowing them to target mutations that will lower toxicity and improve overall effectiveness of the treatment.
A clinical trial at the National Cancer Institute called NCI-MATCH showed how cancer patients could benefit from genomic sequencing and is now informing future trials on precision medicine.
The NCI Molecular Analysis for Therapy Choice Trial initially screened 6,000 patients and treated 1,300 of them by pairing certain medications with their specific tumors regardless of the cancer type. Future trials like ComboMATCH will now look at precision medicine to study how tumors respond to targeted treatments.
NCI Researchers Dr. Lindsay Harris and Dr. Peter O’Dwyer shared how precision oncology is expanding treatment options and increasing patients’ survival rates. They also discuss the importance of clinical trials like these for progressing the fight against cancer.
-
Dr. Lyndsay Harris Associate Director, Cancer Diagnosis Program NCI -
Dr. Peter O'Dwyer Group Co-Chair ECOG-ACRIN Cancer Research Group
-
Inside DOE's Effort to Use AI for Nuclear Waste Cleanup
Eric Pierce explains how Savannah River National Laboratory is using AI to modernize environmental monitoring and waste cleanup.
12m listen -
Wellness Tips for Cyber Leaders at Home
Avni Desai is a dedicated professional at CGI, where she brings a thoughtful blend of leadership, strategic insight and a people‑centered approach to her work.
46m watch -
How Scientists Are Using AI to Analyze the Universe
AstroAI uses AI to identify unexpected patterns in astronomical data, helping scientists uncover new space phenomena.
13m watch -
Inside Federal Acquisition and the Future of Cloud Buying
GSA’s Jonathan Plante discusses how federal cloud acquisition is shifting toward consolidation, transparency, cybersecurity and modernization.
9m watch
